top of page
Executive Spotlights

Nexo Therapeutics Emerges from Steath with $60M Series A Financing

Watertown, MA, and Golden, CO, July 26, 2023 (Business Wire) -- Nexo Therapeutics has made an entrance into the spotlight with an impressive $60 million Series A financing. This investment is spearheaded by Versant Ventures, the founding investor, joined by New Enterprise Associates and Cormorant Asset Management.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page